Euroapi (EAPI) - Wednesday, Nov 29, 2023

Key points

• EAPI is trading at a significant decrease of €5.10 per share, down from previous levels of €12.00-€13.00 before a downward revision of guidance
• The company is undergoing a strategic review after firing the CEO and facing multiple guidance changes, causing investors to lose faith in the management team
• EAPI was previously highlighted as a minimally levered spinout with potential for growth in CDMO work, but customer concentration with Sanofi as a major revenue contributor has been a factor in its discounted value compared to peers like SFZN

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.